Epstein-Barr virus specific antibodies in patients with coeliac disease

Shinji Harada, John Greally, Jack Davis, Nancy Synder, Fiona Stevens, Claran McCarthy, David T. Purtilo

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


SERUM antibodies to Epstein-Barr viral antigens were studied in 56 patients with treated coeliac disease and 53 healthy controls. Four individuals with a malignancy were among the group studied. Twenty-one patients (37.5%) showed unusual antibody response patterns which were broadly divisible into two groups: (1) those with elevated antiviral capsid antigen (VCA), antibodies associated with positive anti-early antigen (EA) responses, and (2) those with low anti-Epstein-Barr nuclear antigen (EBNA) responses. While the results indicate that some patients with coeliac disease have an immunological abnormality with respect to EBV, there is as yet no direct evidence that this results in malignancies.

Original languageEnglish (US)
Pages (from-to)416-421
Number of pages6
JournalIrish Journal of Medical Science
Issue number11
StatePublished - Nov 1985
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Epstein-Barr virus specific antibodies in patients with coeliac disease'. Together they form a unique fingerprint.

Cite this